The myths and realities of hemochromatosis

Canadian Journal of Gastroenterology

Volumn 21, Issue 2, 2007, Pages 101-104

  Beaton, Melanie D ^a   Adams, Paul C ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Genetic testing; Hemochromatosis; Iron

Indexed keywords

CYSTEINE; FERRITIN; HEMOGLOBIN; LIVER ENZYME; TYROSINE;

ALCOHOL LIVER DISEASE; ALCOHOLISM; BLOOD TRANSFUSION; CLINICAL FEATURE; DIABETES MELLITUS; DIAGNOSTIC VALUE; FAMILY COUNSELING; FAMILY STUDY; FERRITIN BLOOD LEVEL; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; HEMOCHROMATOSIS; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOTE; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; IRON OVERLOAD; IRON RESTRICTION; MANAGED CARE; PHLEBOTOMY; PREVALENCE; PRIORITY JOURNAL; RARE DISEASE; REVIEW; SEX DIFFERENCE; VIRUS HEPATITIS;

EID: 33947274182     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/619401     Document Type: Review

References (33)

1. Adams PC, Reboussin DM, Barton JC, et al; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-78.
2. Adams PC. Hemochromatosis case definition: Out of focus? Nat Clin Gastroenterol Hepatol 2006;3:178-9.
3. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med 1997;127:105-10.
4. MacDonald RA. Idiopathic hemochromatosis. Genetic or acquired? Arch Intern Med 1963;112:184-90.
5. Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: Prevalence and clinical consequences among homozygous siblings. Hepatology 1996;23:724-7.
6. Gleeson D, Evans S, Bradley M, et al. HFE genotypes in decompensated alcoholic liver disease: Phenotypic expression and comparison with heavy drinking and with normal controls. Am J Gastroenterol 2006;101:304-10.
7. Adams PC, Passmore L, Chakrabarti S, et al; Hemochromatosis and Iron Overload Screening Study Research Investigators. Liver diseases in the hemochromatosis and iron overload screening study. Clin Gastroenterol Hepatol 2006;4:918-23.
8. Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis 2005;25:461-72.
9. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
10. McClain D, Abraham D, Rogers J, et al. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia 2006;49:1661-9.
11. Hramiak I, Finegood D, Adams PC. Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med 1997;20:110-8.
12. Lin E, Adams PC. Biochemical liver profile in hemochromatosis. A survey of 100 patients. J Clin Gastroenterol 1991;13:316-20.
13. Bhavnani M, Lloyd D, Marples J, Pendry K, Worwood M. Targeted screening for genetic haemochromatosis: A combined phenotype/genotype approach. J Clin Pathol 2006;59:501-4.
14. Wong K, Adams PC. The diversity of liver diseases among outpatient referrals for an elevated serum ferritin. Can J Gastroenterol 2006;20:467-70.
15. Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV. Hepatitis C, iron status, and disease severity: Relationship with HFE mutations. Gastroenterology 2003;124:318-26.
16. Beaton MD, Adams PC. Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis. Can J Gastroenterol 2006;20:257-60.
17. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002;122:281-9.
18. Adams PC, Walker AP, Acton RT. A primer for predicting risk of disease in HFE-linked hemochromatosis. Genet Test 2001;5:311-6.
19. Power TE, Adams PC. Psychosocial impact of C282Y mutation testing for hemochromatosis. Genet Test 2001;5:107-10.
20. Anderson RT, Press N, Tucker DC, et al. Patient acceptability of genotypic testing for hemochromatosis in primary care. Genet Med 2005;7:557-63.
21. Delatycki MB, Allen KJ, Nisselle AE, et al. Use of community genetic screening to prevent HFE-associated hereditary hemochromatosis. Lancet 2005;366:314-6.
22. Greenwood DC, Cade JE, Moreton JA, et al. HFE genotype modifies the influence of heme iron intake on iron status. Epidemiology 2005;16:802-5.
23. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003;361:669-73.
24. Leggett BA, Brown NN, Bryant SJ, Duplock L, Powell LW, Halliday JW. Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Clin Chem 1990;36:1350-5.
25. Adams PC, Gregor J. Hemochromatosis and yersiniosis. Can J Gastroenterol 1990;4:160-2.
26. Lynch SR, Cook JD. Interaction of vitamin C and iron. Ann N Y Acad Sci 1980;355:32-44.
27. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997;25:162-6.
28. Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: Iron overload progression rate. Blood 2004;103:2914-9.
29. Kowdley KV, Brandhagen DJ, Gish RG, et al; National Hemochromatosis Transplant Registry. Survival after liver transplantation in patients with hepatic iron overload: The National Hemochromatosis Transplant Registry. Gastroenterology 2005;129:494-503.
30. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis-associated mortality in the United States from 1979 to 1992: An analysis of Multiple-Cause Mortality Data. Ann Intern Med 1998;129:946-53.
31. Powell LW, Dixon JL, Ramm GA, et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med 2006;166:294-301.
32. Adams PC, Kertesz AE, Valberg LS. Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy. J Clin Gastroenterol 1993;16:207-10.
33. Power TE, Adams PC. Hemochromatosis patients as voluntary blood donors. Can J Gastroenterol 2004;18:393-6.